Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Last days
Enjoy this offer
* See conditions under "Our services"

Valuation: Universal Vision Biotechnology Co., Ltd.

Market Cap 1.16TCr 37Cr 32Cr 29Cr 27Cr 51Cr 3.48TCr 52Cr 345.02Cr 134.77Cr 1.7TCr 138.07Cr 135.14Cr 5.89TCr P/E Ratio 2026 *
10.2x
P/E Ratio 2027 * -
Enterprise Value 1.16TCr 37Cr 32Cr 29Cr 27Cr 51Cr 3.48TCr 52Cr 345.02Cr 134.77Cr 1.7TCr 138.07Cr 135.14Cr 5.89TCr EV / Sales 2026 *
2.72x
EV / Sales 2027 * 2.61x
Free-Float
48.35%
Yield 2026 *
5.87%
Yield 2027 * -
11/05 Universal Vision Biotechnology Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2026 CI
05/03 Universal Vision Biotechnology Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2025 CI
05/03 Universal Vision Biotechnology Co., Ltd. announces Annual dividend, payable on April 22, 2026 CI
12/11 Universal Vision Biotechnology Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025 CI
12/25/12 Universal Vision Biotechnology Co., Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2025 CI
13/25/13 Universal Vision Biotechnology Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2025 CI
06/25/06 Universal Vision Biotechnology Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2024 CI
06/25/06 Universal Vision Biotechnology Co., Ltd. announces Annual dividend, payable on April 21, 2025 CI
13/24/13 Universal Vision Biotechnology Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 CI
12/24/12 Universal Vision Biotechnology Co., Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2024 CI
10/24/10 Universal Vision Biotechnology Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
14/24/14 Universal Vision Biotechnology Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
13/24/13 Universal Vision Biotechnology Co., Ltd. Declares Cash Dividend, Payable on May 20, 2024 CI
1 day+1.48%
1 week+1.48%
Current month-0.72%
1 month+6.20%
3 months-3.86%
6 months-2.84%
Current year-6.16%
1 week 129
Extreme 129
140.5
1 month 125.5
Extreme 125.5
141.5
Current year 122
Extreme 122
154
1 year 122
Extreme 122
219.5
3 years 122
Extreme 122
412.74
5 years 122
Extreme 122
432.08
10 years 18.64
Extreme 18.6433
432.08
Manager TitleAgeSince
Chief Executive Officer - 01/02/2010
Director of Finance/CFO - 01/04/2016
President - -
Director TitleAgeSince
Director/Board Member - 02/06/2003
Chairman - 28/06/2012
Director/Board Member 66 28/06/2012
Change 5-day change 1-year change 3-year change Capi.($)
+1.48%+1.48%-32.18%-63.05% 36Cr
+0.74%+5.75%-23.95%+9.95% 9.72TCr
-0.56%-0.49%-25.44%-26.38% 3.26TCr
+2.14%+1.41%-2.88%-26.29% 1.32TCr
+1.06%-1.40% - - 902.64Cr
+0.18%-8.48%+2.32%+610.17% 239.3Cr
-0.35%-2.42%-25.12%-61.99% 149.63Cr
+1.75%-1.11%-30.83%-30.30% 88Cr
-2.05%-4.16%+2.98%-7.58% 77Cr
-0.24%+0.24%+62.96%-35.58% 76Cr
Average +0.16%-0.47%-8.02%+40.99% 1.59TCr
Weighted average by Cap. +0.35%+2.87%-21.48%+6.98%

Financials

2026 *2027 *
Net sales 427.48Cr 14Cr 12Cr 11Cr 10Cr 19Cr 1.28TCr 19Cr 127.07Cr 50Cr 627.1Cr 51Cr 50Cr 2.17TCr 444.08Cr 14Cr 12Cr 11Cr 10Cr 20Cr 1.33TCr 20Cr 132Cr 52Cr 651.45Cr 53Cr 52Cr 2.25TCr
Net income 114.2Cr 3.62Cr 3.12Cr 2.87Cr 2.69Cr 5.06Cr 342.1Cr 5.11Cr 34Cr 13Cr 167.53Cr 14Cr 13Cr 579.7Cr -
Net Debt - -
Logo Universal Vision Biotechnology Co., Ltd.
UNIVERSAL VISION BIOTECHNOLOGY CO., LTD is a Taiwan-based company principally engaged in the trading of ophthalmic supplies and the provision of eye treatment and related medical services. The Company provides laser vision correction equipment and services, as well as the trading of medical drugs, optical glasses and contact lenses. In addition, the Company is involved in the leasing of medical places, the planning of clinic operation, as well as the provision of medical cosmetology services. The Company operates its businesses mainly in Taiwan market.
Employees
401
Date Price Change Volume
15/26/15 137.00 NT$ +1.48% 3,88,938
12/26/12 135.00 NT$ +3.05% 4,46,511
11/26/11 131.00 NT$ -1.13% 2,52,025
10/26/10 132.50 NT$ -1.49% 2,32,383
09/26/09 134.50 NT$ +2.28% 2,22,997
Trader
-
Investor
-
Global
-
Quality
-
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
2
Last Close Price
137.00TWD
Average target price
150.00TWD
Spread / Average Target
+9.49%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 3218 Stock
- 40% : Our Best Subscriber-Only Tools to Spot Tomorrow’s Top Investments!
d
:
:
SEIZE THE OFFER!